Roche Q3 preview: UBS says 'FX impact turning to a tailwind'

October 21, 2026 6:00 PM

UBS expects limited new strategic news from Roche (OTC: RHHBY) when the Swiss drugmaker reports third-quarter sales on Thursday. In ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found